MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Xylem Inc. (NYSE:XYL - Free Report) by 9.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 44,750 shares of the industrial products company's stock after acquiring an additional 4,021 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in Xylem were worth $5,346,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds and other institutional investors also recently bought and sold shares of the company. OMERS ADMINISTRATION Corp raised its holdings in shares of Xylem by 20.5% in the fourth quarter. OMERS ADMINISTRATION Corp now owns 10,070 shares of the industrial products company's stock worth $1,168,000 after buying an additional 1,716 shares during the last quarter. Nomura Holdings Inc. purchased a new stake in shares of Xylem during the fourth quarter valued at $1,463,000. Mufg Securities Americas Inc. purchased a new stake in shares of Xylem during the fourth quarter valued at $416,000. Quantinno Capital Management LP grew its holdings in shares of Xylem by 148.9% during the fourth quarter. Quantinno Capital Management LP now owns 35,614 shares of the industrial products company's stock valued at $4,132,000 after buying an additional 21,306 shares during the last quarter. Finally, Raiffeisen Bank International AG purchased a new stake in shares of Xylem during the fourth quarter valued at $43,203,000. Hedge funds and other institutional investors own 87.96% of the company's stock.
Xylem Trading Up 2.9%
XYL stock opened at $141.75 on Friday. The company's 50-day simple moving average is $138.01 and its 200-day simple moving average is $127.52. The company has a quick ratio of 1.43, a current ratio of 1.90 and a debt-to-equity ratio of 0.17. Xylem Inc. has a 52-week low of $100.47 and a 52-week high of $145.33. The firm has a market cap of $34.50 billion, a P/E ratio of 36.82, a PEG ratio of 2.38 and a beta of 1.09.
Xylem (NYSE:XYL - Get Free Report) last posted its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.15 by $0.11. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business had revenue of $2.30 billion for the quarter, compared to analyst estimates of $2.20 billion. During the same period in the prior year, the company posted $1.09 EPS. The company's revenue for the quarter was up 6.1% on a year-over-year basis. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. As a group, equities analysts forecast that Xylem Inc. will post 4.65 EPS for the current fiscal year.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend is Thursday, August 28th. Xylem's dividend payout ratio is presently 41.56%.
Insider Activity
In other news, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $139.96, for a total transaction of $139,960.00. Following the sale, the chief accounting officer directly owned 2,957 shares of the company's stock, valued at $413,861.72. This represents a 25.27% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. 0.27% of the stock is currently owned by insiders.
Analyst Upgrades and Downgrades
A number of brokerages have recently weighed in on XYL. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a report on Saturday, August 9th. Raymond James Financial raised shares of Xylem to a "hold" rating in a report on Thursday, May 15th. Stifel Nicolaus boosted their price objective on shares of Xylem from $162.00 to $175.00 and gave the company a "buy" rating in a report on Friday, August 1st. JPMorgan Chase & Co. began coverage on shares of Xylem in a report on Friday, May 30th. They set an "overweight" rating and a $148.00 target price for the company. Finally, Cowen reissued a "hold" rating on shares of Xylem in a report on Tuesday, August 26th. Six analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, Xylem has an average rating of "Moderate Buy" and an average price target of $152.29.
View Our Latest Stock Analysis on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Featured Articles
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.